Searcharxiv⌕ Search

arXiv subjects

Silvia Giulia Galfré

Publications and source records attributed to Silvia Giulia Galfré.

2 recordsLinked to original sources

Knowledge Graph Extraction from Biomedical Literature for Alkaptonuria Rare Disease

Alkaptonuria (AKU) is an ultra-rare autosomal recessive metabolic disorder caused by mutations in the HGD (Homogentisate 1,2-Dioxygenase) gene, leading to a pathological accumulation of homogentisic acid (HGA) in body fluids and tissues. This leads to systemic manifestations, including premature spondyloarthropathy, renal and prostatic stones, and cardiovascular complications. Being ultra-rare, the amount of data related to the disease is limited, both in terms of clinical data and literature. Knowledge graphs (KGs) can help connect the limited knowledge about the disease (basic mechanisms, manifestations and existing therapies) with other knowledge; however, AKU is frequently underrepresented or entirely absent in existing biomedical KGs. In this work, we apply a text-mining methodology based on PubTator3 for large-scale extraction of biomedical relations. We construct two KGs of different sizes, validate them using existing biochemical knowledge and use them to extract genes, diseases and therapies possibly related to AKU. This computational framework reveals the systemic interactions of the disease, its comorbidities, and potential therapeutic targets, demonstrating the efficacy of our approach in analyzing rare metabolic disorders.

cs.AI↗

Machine Learning for analysis of Multiple Sclerosis cross-tissue bulk and single-cell transcriptomics data

Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system whose molecular mechanisms remain incompletely understood. In this study, we developed an end-to-end machine learning pipeline to analyze transcriptomic data from peripheral blood mononuclear cells and cerebrospinal fluid, integrating both bulk microarray and single-cell RNA sequencing datasets (concentrating on CD4+ and B-cells). After rigorous preprocessing, batch correction, and gene declustering, XGBoost classifiers were trained to distinguish MS patients from healthy controls. Explainable AI tools, namely SHapley Additive exPlanations (SHAP), were employed to identify key genes driving classification, and results were compared with Differential Expression Analysis (DEA). SHAP-prioritized genes were further investigated through interaction networks and pathway enrichment analyses. The models achieved strong performance, particularly in CSF B-cells (AUC=0.94) and microarray (AUC=0.86). SHAP gene selection proved to be complementary to classical DEA. Gene clusters identified across multiple datasets highlighted immune activation, non-canonical immune checkpoints (ITK, CLEC2D, KLRG1, CEACAM1), ribosomal and translational programs, ubiquitin-proteasome regulation, lipid trafficking, and Epstein-Barr virus-related pathways. Our integrative and explainable framework reveals complementary insights beyond conventional analysis and provides novel mechanistic hypotheses and potential biomarkers for MS pathogenesis.

q-bio.GN↗